Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model

Neuron. 2004 Sep 2;43(5):633-45. doi: 10.1016/j.neuron.2004.08.013.

Abstract

Learning and memory depend on dendritic spine actin assembly and docosahexaenoic acid (DHA), an essential n-3 (omega-3) polyunsaturated fatty acid (PFA). High DHA consumption is associated with reduced Alzheimer's disease (AD) risk, yet mechanisms and therapeutic potential remain elusive. Here, we report that reduction of dietary n-3 PFA in an AD mouse model resulted in 80%-90% losses of the p85alpha subunit of phosphatidylinositol 3-kinase and the postsynaptic actin-regulating protein drebrin, as in AD brain. The loss of postsynaptic proteins was associated with increased oxidation, without concomitant neuron or presynaptic protein loss. n-3 PFA depletion increased caspase-cleaved actin, which was localized in dendrites ultrastructurally. Treatment of n-3 PFA-restricted mice with DHA protected against these effects and behavioral deficits and increased antiapoptotic BAD phosphorylation. Since n-3 PFAs are essential for p85-mediated CNS insulin signaling and selective protection of postsynaptic proteins, these findings have implications for neurodegenerative diseases where synaptic loss is critical, especially AD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Alzheimer Disease / prevention & control*
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / pathology
  • Carrier Proteins / drug effects
  • Carrier Proteins / metabolism
  • Dendrites / drug effects*
  • Dendrites / metabolism*
  • Dendrites / pathology
  • Dietary Fats, Unsaturated / metabolism
  • Dietary Fats, Unsaturated / pharmacology
  • Disease Models, Animal
  • Docosahexaenoic Acids / metabolism
  • Docosahexaenoic Acids / pharmacology*
  • Docosahexaenoic Acids / therapeutic use
  • Down-Regulation / genetics
  • Female
  • Food, Formulated
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Microscopy, Electron
  • Nerve Tissue Proteins / metabolism
  • Neuropeptides / metabolism
  • Oxidative Stress / drug effects
  • Oxidative Stress / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation / drug effects
  • Protein Subunits / metabolism
  • Synapses / drug effects
  • Synapses / metabolism
  • Synapses / pathology
  • bcl-Associated Death Protein

Substances

  • Actins
  • BAD protein, human
  • Bad protein, mouse
  • Carrier Proteins
  • Dietary Fats, Unsaturated
  • Nerve Tissue Proteins
  • Neuropeptides
  • Protein Subunits
  • bcl-Associated Death Protein
  • drebrins
  • Docosahexaenoic Acids
  • Phosphatidylinositol 3-Kinases